Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CMTG NYSEAMERICAN:LPA NYSE:MLP NASDAQ:SMMT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMTGClaros Mortgage Trust$2.42-0.6%$2.39$2.05▼$3.99$338.63M1.14493,975 shs191,943 shsLPALogistic Properties of the Americas$2.99+0.7%$3.32$2.04▼$8.34$94.54M5.2920,904 shs5,612 shsMLPMaui Land & Pineapple$16.83-0.6%$15.95$13.84▼$20.34$334.24M0.6816,530 shs3,765 shsSMMTSummit Therapeutics$16.13-8.1%$19.06$13.83▼$30.98$12.50B-1.323.45 million shs14.33 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMTGClaros Mortgage Trust0.00%+12.93%-7.56%+6.07%-4.49%LPALogistic Properties of the Americas0.00%-4.19%-16.81%+18.80%-63.82%MLPMaui Land & Pineapple0.00%-1.35%+9.36%+0.52%+7.41%SMMTSummit Therapeutics0.00%+5.54%-18.27%+8.34%-6.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMTGClaros Mortgage Trust$2.42-0.6%$2.39$2.05▼$3.99$338.63M1.14493,975 shs191,943 shsLPALogistic Properties of the Americas$2.99+0.7%$3.32$2.04▼$8.34$94.54M5.2920,904 shs5,612 shsMLPMaui Land & Pineapple$16.83-0.6%$15.95$13.84▼$20.34$334.24M0.6816,530 shs3,765 shsSMMTSummit Therapeutics$16.13-8.1%$19.06$13.83▼$30.98$12.50B-1.323.45 million shs14.33 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMTGClaros Mortgage Trust0.00%+12.93%-7.56%+6.07%-4.49%LPALogistic Properties of the Americas0.00%-4.19%-16.81%+18.80%-63.82%MLPMaui Land & Pineapple0.00%-1.35%+9.36%+0.52%+7.41%SMMTSummit Therapeutics0.00%+5.54%-18.27%+8.34%-6.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCMTGClaros Mortgage Trust 1.50Reduce$2.9223.85% UpsideLPALogistic Properties of the Americas 2.00Hold$7.50151.42% UpsideMLPMaui Land & Pineapple 1.00SellN/AN/ASMMTSummit Therapeutics 2.35Hold$26.0561.47% UpsideCurrent Analyst Ratings BreakdownLatest LPA, SMMT, MLP, and CMTG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/1/2026SMMTSummit Therapeutics KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/26/2026CMTGClaros Mortgage Trust Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/24/2026LPALogistic Properties of the AmericasBtg PactualSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$7.505/22/2026SMMTSummit Therapeutics Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/22/2026SMMTSummit Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral5/21/2026SMMTSummit Therapeutics Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageUnderperform$7.705/21/2026SMMTSummit Therapeutics Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell5/13/2026CMTGClaros Mortgage Trust Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderperform$2.50 ➝ $2.255/13/2026LPALogistic Properties of the Americas Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/8/2026CMTGClaros Mortgage Trust Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/4/2026SMMTSummit Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$30.00 ➝ $23.00(Data available from 6/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCMTGClaros Mortgage Trust$187.83M1.76N/AN/A$10.93 per share0.22LPALogistic Properties of the Americas$50.13M1.88$0.37 per share8.16$10.27 per share0.29MLPMaui Land & Pineapple$19.46M17.52N/AN/A$1.67 per share10.28SMMTSummit TherapeuticsN/AN/AN/AN/A$0.85 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCMTGClaros Mortgage Trust-$489.07M-$3.32N/AN/AN/A-267.14%-19.34%-6.27%8/5/2026 (Estimated)LPALogistic Properties of the Americas$10.50MN/A29.833.59N/A6.31%1.08%0.49%8/12/2026 (Estimated)MLPMaui Land & Pineapple-$10.58M-$0.20N/AN/AN/A-23.44%-12.78%-8.53%8/13/2026 (Estimated)SMMTSummit Therapeutics-$1.08B-$1.60N/AN/AN/AN/A-291.24%-243.07%8/10/2026 (Estimated)Latest LPA, SMMT, MLP, and CMTG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026MLPMaui Land & PineappleN/A-$0.10N/A-$0.10N/A$3.41 million5/14/2026Q1 2026LPALogistic Properties of the AmericasN/A-$0.25N/A-$0.25N/A$14.40 million5/6/2026Q1 2026CMTGClaros Mortgage Trust-$0.2384-$0.52-$0.2816-$0.39$36.94 million$29.52 million5/1/2026Q1 2026SMMTSummit Therapeutics-$0.2692-$0.24+$0.0292-$0.24$0.05 millionN/A3/31/2026Q4 2025MLPMaui Land & PineappleN/A-$0.06N/A-$0.06N/A$4.53 million3/18/2026Q4 2025LPALogistic Properties of the AmericasN/A$0.1950N/A$0.1950N/A$13.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCMTGClaros Mortgage TrustN/AN/AN/AN/AN/ALPALogistic Properties of the AmericasN/AN/AN/AN/AN/AMLPMaui Land & PineappleN/AN/AN/AN/AN/ASMMTSummit TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCMTGClaros Mortgage Trust1.5321.4421.44LPALogistic Properties of the Americas0.931.571.57MLPMaui Land & Pineapple0.211.381.38SMMTSummit TherapeuticsN/A7.417.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCMTGClaros Mortgage Trust89.53%LPALogistic Properties of the Americas42.71%MLPMaui Land & Pineapple24.55%SMMTSummit Therapeutics4.61%Insider OwnershipCompanyInsider OwnershipCMTGClaros Mortgage Trust1.80%LPALogistic Properties of the Americas32.00%MLPMaui Land & Pineapple68.60%SMMTSummit Therapeutics83.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCMTGClaros Mortgage TrustN/A140.22 million137.70 millionOptionableLPALogistic Properties of the Americas3031.62 million21.50 millionN/AMLPMaui Land & Pineapple919.86 million6.24 millionNot OptionableSMMTSummit Therapeutics110776.16 million128.07 millionOptionableLPA, SMMT, MLP, and CMTG HeadlinesRecent News About These CompaniesWall Street Analysts Think Summit Therapeutics (SMMT) Could Surge 67.1%: Read This Before Placing a Bet2 hours ago | zacks.comSummit rises after lung cancer drug trial shows 15% higher survival rate than rival'sJune 1 at 6:34 AM | reuters.comIvonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONMay 31 at 12:05 PM | gurufocus.comIvonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in ChinaMay 31 at 9:06 AM | businesswire.comA hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in ChinaMay 31 at 8:00 AM | cnbc.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down - Here's What HappenedMay 24, 2026 | americanbankingnews.comSummit downgraded at H.C. Wainwright after Merck data for sac-TMTMay 23, 2026 | seekingalpha.comBernstein initiates coverage of Summit Therapeutics (SMMT) with underperform recommendationMay 23, 2026 | msn.comHere's Why You Should Add SMMT Stock to Your Portfolio NowMay 22, 2026 | zacks.comCancer Stocks That Are Advancing the Future of Oncology CareMay 18, 2026 | zacks.comSummit Therapeutics PLC $SMMT Stock Holdings Decreased by Vanguard Group Inc.May 11, 2026 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Upgraded at Wall Street ZenMay 10, 2026 | marketbeat.comQ2 EPS Estimate for Summit Therapeutics Boosted by AnalystMay 8, 2026 | marketbeat.comQ2 Earnings Forecast for SMMT Issued By HC WainwrightMay 7, 2026 | marketbeat.comSMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab SetbackMay 4, 2026 | zacks.comSummit Therapeutics: More Uncertainty Heading Into The ASCO PlenaryMay 4, 2026 | seekingalpha.comBuy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash RunwaysMay 4, 2026 | 247wallst.comSummit Therapeutics Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesMay 4, 2026 | globenewswire.comHC Wainwright Issues Pessimistic Forecast for Summit Therapeutics (NASDAQ:SMMT) Stock PriceMay 4, 2026 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Summit Therapeutics (SMMT)May 3, 2026 | theglobeandmail.comSummit Therapeutics (SMMT) Receives a Rating Update from a Top AnalystMay 3, 2026 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLPA, SMMT, MLP, and CMTG Company DescriptionsClaros Mortgage Trust NYSE:CMTG$2.42 -0.02 (-0.62%) As of 12:56 PM Eastern This is a fair market value price provided by Massive. Learn more.Claros Mortgage Trust, Inc. operates as a real estate investment trust. It focuses on originating senior and subordinate loans on transitional commercial real estate assets in the United States. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was incorporated in 2015 and is headquartered in New York, New York.Logistic Properties of the Americas NYSEAMERICAN:LPA$2.99 +0.02 (+0.67%) As of 12:56 PM Eastern This is a fair market value price provided by Massive. Learn more.Logistic Properties of the Americas develops, builds and operates logistic real estate properties. It operates through the following geographical segments: Colombia, Peru, and Costa Rica. The company is headquartered in Miami, FL.Maui Land & Pineapple NYSE:MLP$16.83 -0.10 (-0.59%) As of 12:55 PM Eastern This is a fair market value price provided by Massive. Learn more.Maui Land & Pineapple Co., Inc. is a landholding and operating company, which engages in the development, sale, and management of real estate. It operates through the following segments: Real Estate, Leasing, and Resort Amenities. The Real Estate segment includes land planning and entitlement, development, and sales activities. The Leasing segment consists of residential, resort, commercial, agricultural and industrial land and property leases, licensing of registered trademarks and trade names, and stewardship and conservation efforts. The Resort Amenities segment manages a full-service spa, a beach club, and a private club membership program. The company was founded in 1909 and is headquartered in Maui, HI.Summit Therapeutics NASDAQ:SMMT$16.13 -1.41 (-8.06%) As of 12:57 PM Eastern This is a fair market value price provided by Massive. Learn more.Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab, as well as strategic collaboration with The University of Texas MD Anderson Cancer Center for the purpose of accelerating the development of ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/25 - 05/29 Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17% What Exactly Is Agentic AI, and Why Are Some Stocks Blowing Up Because of It? Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem SanDisk's Stock and Short Interest Both at Record Highs —Do the Bears Know Something? MongoDB's AI Advantage Is Starting to Show Up in Results 3 Ways to Play the Data Center Land Grab Alphabet Bets on Hardware With Googlebook and AI Glasses Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
